Gastroenterology & Hepatology

Liver Fibrosis and Cirrhosis

Researchers are invited to submit abstracts for the "Liver Fibrosis and Cirrhosis" track at GASTROENTEROLOGY-2024. This track will focus on advancing our understanding and management of liver fibrosis and cirrhosis, critical stages in the progression of chronic liver diseases.

Abstract submissions should highlight novel insights into the pathophysiology of fibrosis, diagnostic innovations, prognostic markers, and therapeutic strategies aimed at preventing or reversing fibrosis progression. Topics of interest include non-invasive assessment techniques, biomarkers of fibrosis regression, personalized medicine approaches, and the impact of comorbidities on disease outcomes.

What to Expect:

Attendees can anticipate comprehensive sessions featuring expert presentations on the latest research findings, clinical trials, and therapeutic developments in liver fibrosis and cirrhosis. The track will explore emerging treatments such as antifibrotic therapies, liver transplantation advancements, and the role of lifestyle interventions in disease management.

Join us at GASTROENTEROLOGY-2024 to contribute to the dialogue on liver fibrosis and cirrhosis, collaborate with peers, and explore innovative strategies aimed at improving patient outcomes and quality of life.